Volek, J.S., Kraemer, W.J., Rubin, M.R., Gmez, A.L., Ratamess, N.A
doi: 10.3389/fpsyg.2020.530425 23 JensenMDRyanDHApovianCMArdJDComuzzieAGDonatoKAet al
BPC-157 PEPTIDE LIQUID SPRAY 15ML BOTTLE 0 out of 5 $49.99 $94.99Price range: $49.99 through $94.99 BPC-157 is sold for laboratory research use only
Animal research has revealed both the central and peripheral effects of GLP-1RA in modulating brain-gut signals, appetite circuits, and cravings through dopaminergic and serotonin pathways
Meal prepping and maintaining a consistent workout routine require a significant time investment, which can feel overwhelming for those juggling work, family, and other responsibilities
Key benefits Why people compare it 1 14.9% mean body weight reduction demonstrated in STEP 1 trial (N=1,961) 2 20% reduction in major adverse cardiovascular events in SELECT trial (N=17,604) 3 Significant reduction in appetite and food cravings via hypothalamic POMC/CART activation 4 Improved glycemic control with glucose-dependent insulin secretion potentiation 5 Once-weekly dosing enabled by 165-hour plasma half-life and albumin binding 6 86.4% of STEP 1 participants achieved at least 5% body weight loss 7 Demonstrated NAFLD/NASH improvement with reduction in liver fat content 8 Well-characterized safety profile from over 30,000 participants across STEP and SELECT programs Deep research Semaglutide (chemical name: N-epsilon26-[2-(2-[2-(2-[2-(2-((S)-2-carboxy-3-((1S,2R)-3-carboxy-1-(carboxymethyl-carbamoyl)-propylcarbamoyl)-propionylamino)-ethoxy)-ethoxy)-acetylamino]-ethoxy)-ethoxy)-acetyl]-[Aib8,Arg34]-GLP-1-(7-37)-peptide) is a 39-amino-acid peptide with a molecular weight of 4,113.58 Da
